Secretin available under FDA treatment protocol.
Calis
Karim Anton
KA
Daniels
Charles E
CE
D017277:Drug Approval; D012633:Secretin / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D012633:Secretin